Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PHEND-HD: Phenylbutyrate in Huntington's Disease
NCT00212316Phase 2Completed
- Sponsor
- University of Rochester
- Start
- Aug 2005
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of sodium phenylbutyrate in Huntington's disease (HD), sponsored by University of Rochester. Started Aug 2005; status: completed.
02
Drugs
sodium phenylbutyrate
03
Conditions
Huntington's disease (HD)
Beyond the preview
Go deeper on NCT00212316.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00212316.